Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Otero

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Medicina Clinica|June 26, 2007
[High prevalence of left ventricular hypertrophy in patients with hypertension of long course]José María Fernández Villaverde, Francisco Javier Maestro Saavedra, Germán Allut Vidal, et al.
American Heart Journal|November 27, 2008
Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term studyLilian Grigorian-Shamagian, Fernando Otero Raviña, Emad Abu Assi, et al.
Revista Espanola De Cardiologia|November 13, 2010
Effect of diabetes on the clinical characteristics and prognosis of patients with chronic ischemic heart disease. The CIBAR studyFernando Otero Raviña, Pilar Mazón-Ramos, Lilian Grigorian-Shamagian, et al.
International Journal of Cardiology|September 15, 2010
Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study)Alberto García-Castelo, Javier García-Seara, Fernando Otero-Raviña, et al.
Revista Espanola De Cardiologia|November 13, 2008
[Effect of the location of previous atherosclerotic disease on prognosis in diabetic patients. The Barbanza Diabetes Study]José R González-Juanatey, Lilian Grigorian-Shamagian, María A Juiz-Crespo, et al.
International Journal of Cardiology|February 7, 2012
Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) studyRafael Vidal-Perez, Fernando Otero-Raviña, Manuel Franco, et al.
Revista Espanola De Cardiologia (English Ed.)|December 3, 2014
Outcomes of a contemporary sample of patients with atrial fibrillation taking digoxin: results from the AFBAR studyMoisés Rodríguez-Mañero, Fernando Otero-Raviña, Javier García-Seara, et al.
International Journal of Cardiology|March 5, 2013
The change in the atrial fibrillation type as a prognosis marker in a community study: long-term data from AFBAR (Atrial Fibrillation in the BARbanza) studyRafael Vidal-Perez, Fernando Otero-Raviña, Manuel Lado-López, et al.
Clinical Cardiology|March 14, 2002
Correlation between myocardial perfusion abnormalities detected with intermittent imaging using intravenous perfluorocarbon microbubbles and radioisotope imaging during high-dose dipyridamole stress echoRicardo E Ronderos, Mario Boskis, Namsik Chung, et al.
Revista De Neurologia|October 1, 2011
[Clinical features and prognosis of patients with chronic cerebrovascular disease (ICBAR study)]Rafael Vidal-Pérez, Fernando Otero-Raviña, Jerónimo Domínguez-López, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Medicina Clinica|June 26, 2007
[High prevalence of left ventricular hypertrophy in patients with hypertension of long course]José María Fernández Villaverde, Francisco Javier Maestro Saavedra, Germán Allut Vidal, et al.
American Heart Journal|November 27, 2008
Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term studyLilian Grigorian-Shamagian, Fernando Otero Raviña, Emad Abu Assi, et al.
Revista Espanola De Cardiologia|November 13, 2010
Effect of diabetes on the clinical characteristics and prognosis of patients with chronic ischemic heart disease. The CIBAR studyFernando Otero Raviña, Pilar Mazón-Ramos, Lilian Grigorian-Shamagian, et al.
International Journal of Cardiology|September 15, 2010
Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study)Alberto García-Castelo, Javier García-Seara, Fernando Otero-Raviña, et al.
Revista Espanola De Cardiologia|November 13, 2008
[Effect of the location of previous atherosclerotic disease on prognosis in diabetic patients. The Barbanza Diabetes Study]José R González-Juanatey, Lilian Grigorian-Shamagian, María A Juiz-Crespo, et al.
International Journal of Cardiology|February 7, 2012
Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) studyRafael Vidal-Perez, Fernando Otero-Raviña, Manuel Franco, et al.
Revista Espanola De Cardiologia (English Ed.)|December 3, 2014
Outcomes of a contemporary sample of patients with atrial fibrillation taking digoxin: results from the AFBAR studyMoisés Rodríguez-Mañero, Fernando Otero-Raviña, Javier García-Seara, et al.
International Journal of Cardiology|March 5, 2013
The change in the atrial fibrillation type as a prognosis marker in a community study: long-term data from AFBAR (Atrial Fibrillation in the BARbanza) studyRafael Vidal-Perez, Fernando Otero-Raviña, Manuel Lado-López, et al.
Clinical Cardiology|March 14, 2002
Correlation between myocardial perfusion abnormalities detected with intermittent imaging using intravenous perfluorocarbon microbubbles and radioisotope imaging during high-dose dipyridamole stress echoRicardo E Ronderos, Mario Boskis, Namsik Chung, et al.
Revista De Neurologia|October 1, 2011
[Clinical features and prognosis of patients with chronic cerebrovascular disease (ICBAR study)]Rafael Vidal-Pérez, Fernando Otero-Raviña, Jerónimo Domínguez-López, et al.
Pageof 3